Clinical Trial Update: Derivation of Tumor Specific Hybridomas [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at Dartmouth-Hitchcock Medical Center investigating derivation of tumor-specific hybridomas for glioblastoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Glioblastoma | Phase 1 | Status: TERMINATED